Clinical impact of febrile neutropenia (FN) increase among patients receiving adjuvant docetaxel/cyclophosphamide (TC) chemotherapy compared to TC plus pegfilgrastim for breast cancer.
Erika Paige Hamilton
No relevant relationships to disclose
Donna L. Topping
No relevant relationships to disclose
Jeffrey M. Peppercorn
Employment or Leadership Position - GlaxoSmithKline (I)
Consultant or Advisory Role - Bayer; Genentech
Stock Ownership - GlaxoSmithKline (I)
P. Kelly Marcom
No relevant relationships to disclose
Gretchen Genevieve Kimmick
Honoraria - CHAMBER Foundation
Research Funding - Bionovo; Bristol-Myers Squibb; GlaxoSmithKline; Wyeth
Other Remuneration - AstraZeneca; Genomic Health; Novartis; Pfizer
Erin Duff
No relevant relationships to disclose
Constance T. Cirrincione
No relevant relationships to disclose
Kimberly L. Blackwell
Honoraria - Amgen